JP2001517456A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517456A5 JP2001517456A5 JP2000512983A JP2000512983A JP2001517456A5 JP 2001517456 A5 JP2001517456 A5 JP 2001517456A5 JP 2000512983 A JP2000512983 A JP 2000512983A JP 2000512983 A JP2000512983 A JP 2000512983A JP 2001517456 A5 JP2001517456 A5 JP 2001517456A5
- Authority
- JP
- Japan
- Prior art keywords
- ache
- glycosylation pattern
- wga
- con
- isoform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100033639 Acetylcholinesterase Human genes 0.000 description 33
- 108010022752 Acetylcholinesterase Proteins 0.000 description 33
- 229940022698 acetylcholinesterase Drugs 0.000 description 33
- 238000000034 method Methods 0.000 description 22
- 230000013595 glycosylation Effects 0.000 description 17
- 238000006206 glycosylation reaction Methods 0.000 description 17
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 16
- 108010062580 Concanavalin A Proteins 0.000 description 15
- 102000001708 Protein Isoforms Human genes 0.000 description 10
- 108010029485 Protein Isoforms Proteins 0.000 description 10
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000001594 aberrant effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108010053652 Butyrylcholinesterase Proteins 0.000 description 2
- 102100032404 Cholinesterase Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 101100379079 Emericella variicolor andA gene Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU9432 | 1996-04-22 | ||
| AUPO9432A AUPO943297A0 (en) | 1997-09-24 | 1997-09-24 | Diagnostic test for alzheimer's disease |
| PCT/AU1998/000809 WO1999015695A1 (en) | 1997-09-24 | 1998-09-24 | Diagnostic test for alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001517456A JP2001517456A (ja) | 2001-10-09 |
| JP2001517456A5 true JP2001517456A5 (enExample) | 2006-01-05 |
Family
ID=3803714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000512983A Pending JP2001517456A (ja) | 1997-09-24 | 1998-09-24 | アルツハイマー病の診断試験 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6461831B1 (enExample) |
| EP (1) | EP1017845B1 (enExample) |
| JP (1) | JP2001517456A (enExample) |
| AT (1) | ATE323781T1 (enExample) |
| AU (1) | AUPO943297A0 (enExample) |
| BR (1) | BR9813015A (enExample) |
| CA (1) | CA2304949A1 (enExample) |
| DE (1) | DE69834263D1 (enExample) |
| HU (1) | HUP0003684A3 (enExample) |
| IL (1) | IL135211A0 (enExample) |
| WO (1) | WO1999015695A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL130225A0 (en) | 1999-05-31 | 2000-06-01 | Yissum Res Dev Co | Novel uses of antibodies against ache and peptides thereof |
| US20020150878A1 (en) * | 2001-01-23 | 2002-10-17 | Small David Henry | Method for the diagnosis of Alzheimer's Disease and other prion related disorders |
| WO2004066808A2 (en) * | 2002-12-20 | 2004-08-12 | Momenta Pharmaceuticals, Inc. | Glycan markers for diagnosing and monitoring disease |
| GB2404734A (en) * | 2003-08-05 | 2005-02-09 | Secr Defence | A method of screening a sample for abnormally glycosylated and/or expressed proteins |
| AU2004294178C1 (en) * | 2003-11-19 | 2011-10-27 | Rules-Based Medicine, Inc. | Methods for diagnosis, stratification, and monitoring of Alzheimer's disease |
| US20060094064A1 (en) * | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| US20050272643A1 (en) * | 2004-06-08 | 2005-12-08 | Windber Research Institute | Removal of serum albumin from human serum or plasma |
| US7851172B2 (en) | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
| US20100124756A1 (en) * | 2008-10-10 | 2010-05-20 | Sandip Ray | Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids |
| US20110237537A1 (en) * | 2009-05-29 | 2011-09-29 | Lombard Jay L | Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis |
| US8355927B2 (en) | 2010-11-05 | 2013-01-15 | Genomind, Llc | Neuropsychiatric test reports |
| ES2581178T3 (es) | 2009-07-29 | 2016-09-01 | Pharnext | Nuevas herramientas de diagnóstico para enfermedad de Alzheimer |
| US20110202284A1 (en) * | 2010-02-10 | 2011-08-18 | Mcreynolds Cristopher | Novel groups of biomarkers for diagnosing alzheimer's disease |
| ES2395063B1 (es) * | 2011-03-04 | 2014-02-07 | Universidad Miguel Hernández De Elche | Método para determinar la enfermedad de Alzheimer mediante la detección de glicoproteínas portadoras del glicoepítopo HNK-1 |
| AU2013246621A1 (en) | 2012-04-13 | 2014-11-27 | Oasis Diagnostics Corporation | Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of Alzheimer's and Parkinson's diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595883A (en) * | 1990-06-01 | 1997-01-21 | E. R. Squibb & Sons, Inc. | Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid |
| US5200324A (en) * | 1990-09-04 | 1993-04-06 | E. R. Squibb & Sons, Inc. | Method of diagnosing senile dementia of the Alzheimer type |
| CA2048700A1 (en) | 1990-09-04 | 1992-03-05 | Dasakumar S. Navaratnam | Method for diagnosing senile dementia of the alzheimer type |
-
1997
- 1997-09-24 AU AUPO9432A patent/AUPO943297A0/en not_active Abandoned
-
1998
- 1998-09-24 JP JP2000512983A patent/JP2001517456A/ja active Pending
- 1998-09-24 WO PCT/AU1998/000809 patent/WO1999015695A1/en not_active Ceased
- 1998-09-24 BR BR9813015-3A patent/BR9813015A/pt not_active IP Right Cessation
- 1998-09-24 IL IL13521198A patent/IL135211A0/xx unknown
- 1998-09-24 HU HU0003684A patent/HUP0003684A3/hu unknown
- 1998-09-24 CA CA002304949A patent/CA2304949A1/en not_active Abandoned
- 1998-09-24 DE DE69834263T patent/DE69834263D1/de not_active Expired - Lifetime
- 1998-09-24 AT AT98946146T patent/ATE323781T1/de not_active IP Right Cessation
- 1998-09-24 US US09/509,203 patent/US6461831B1/en not_active Expired - Fee Related
- 1998-09-24 EP EP98946146A patent/EP1017845B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001517456A5 (enExample) | ||
| Ploug et al. | Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator | |
| GB2380546A (en) | Process for differential diagnosis of alzheimer's dementia and device therefor | |
| JP2002533680A5 (enExample) | ||
| AU2003220041A1 (en) | Apparatus and methods for analyte measurement and immunoassay | |
| WO2007001342A3 (en) | Exhaled breath condensate collection and assay system and method | |
| WO2002046746A3 (en) | Method for detection of vitamin d metabolites | |
| WO2002082075A3 (de) | Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien | |
| JP2008537111A (ja) | 精神医学的状態のための神経変性マーカー | |
| AUPO943297A0 (en) | Diagnostic test for alzheimer's disease | |
| CA2264939A1 (en) | Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes | |
| Bröijersén et al. | Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII | |
| US5998132A (en) | Method and apparatus for detecting cancer, influenza, or HIV based on α-N-acetyl-galactosaminidase detection | |
| WO2004082455A3 (en) | Method for detecting alzheimer’s disease and corresponding peptides and detection reagents | |
| WO2001063293A8 (en) | Diagnosis and treatment of schizophrenia | |
| Olofsson et al. | The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC | |
| WO1998046993A3 (en) | Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor | |
| WO2001069261A3 (en) | Proteins, genes and their use for diagnosis and treatment of vascular dementia | |
| US5776671A (en) | Diagnostic and prognostic ELISA assays of serum α-N-acetylgalactosaminidase for influenza | |
| AU4937800A (en) | Diagnosis of chronic obstructive pulmonary disease | |
| CA2332310A1 (en) | Antibody against protein tyrosine phosphatase intracellular domains | |
| JPWO2005040798A1 (ja) | アルツハイマー病の診断方法 | |
| JP2003508059A5 (enExample) | ||
| JP2002539455A5 (enExample) | ||
| AU5693300A (en) | Method of diagnosis |